Tchaikapharma High Quality Medicines AD (BUL: THQM)

Market Cap	1.60B
Revenue (ttm)	49.39M
Net Income (ttm)	1.92M
Shares Out	91.80M
EPS (ttm)	0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Open	17.40
Previous Close	n/a
Day's Range	17.40 - 17.40
52-Week Range	16.50 - 17.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2024

About THQM

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements. The company was founded in 1999 and is headquartered in Sofia, Bulgaria.

• Industry: Pharmaceutical Preparations
• Founded: 1999
• Employees: 191
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: THQM

Financial Performance

In 2023, THQM's revenue was 48.51 million, an increase of 12.44% compared to the previous year's 43.15 million. Earnings were 3.40 million, an increase of 21.79%.